POS-810 SECONDARY HYPERPARATHYROIDISM: A CARDIOVASCULAR RISK FACTOR FOR KIDNEY DISEASE

POS-810 SECONDARY HYPERPARATHYROIDISM: A CARDIOVASCULAR RISK FACTOR FOR KIDNEY DISEASE

Bibliographic Details
Main Authors:	B.A. SHEDHA, M. Najjar, S. Barbouch, F. Ben Hmida, T. Ben Abdallah
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S246802492100989X

Similar Items

POS-617 GERIATIC HEMODIALYSIS PATIENTS: PREVALENCE AND RISK FACTORS
by: B.A. SHEDHA, et al.
Published: (2021-04-01)

POS-250 HYPERPARATHYROIDISM: A CARDIOVASCULAR RISK FACTOR IN CHRONIC HEMODIALYSIS?
by: H. Bouafif, et al.
Published: (2021-04-01)

POS-616 Cutaneous manifestations in hemodialysis patients
by: B.A. SHEDHA, et al.
Published: (2021-04-01)

POS-122 MULTIPLE MYELOMA AND ACUTE KIDNEY DISEASE: RISK FACTORS AND RENAL PROGNOSIS
by: C. TRIQUI, et al.
Published: (2021-04-01)

POS-249 PARATHYROIDECTOMY: DOES IT REDUCE CARDIOVASCULAR RISK IN HEMODIALYSIS?
by: H. Bouafif, et al.
Published: (2021-04-01)

Brown tumors in patients with chronic renal failure and secondary hyperparathyroidism: Report of 12 cases
by: Fatma Lilia, et al.
Published: (2010-01-01)

POS-102 ETIOLOGICAL PROFILE OF HYPERTENSION IN LUPUS NEPHRITIS
by: H. KAZDAGHLI, et al.
Published: (2021-04-01)

POS-138 SEVERE INFECTIONS IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS: CLINICO-BACTERIOLOGICAL PROFILE AND RISK FACTORS
by: N. CHERNI, et al.
Published: (2021-04-01)

Secondary and tertiary hyperparathyroidism in chronic kidney disease
by: Lilit V. Egshatyan, et al.
Published: (2017-12-01)

Risk factors of hyperparathyroidism in advanced stages of chronic kidney disease
by: El Kossi M, et al.
Published: (2009-01-01)

Secondary hyperparathyroidism in diabetic kidney disease patients treated with hemodialysis
by: I.O. Dudar, et al.
Published: (2023-01-01)

Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease
by: Tally Naveh-Many, et al.
Published: (2020-06-01)

Role of cinacalcet in the treatment of secondary hyperparathyroidism in chronic kidney disease
by: H.K. Aggarwal, et al.
Published: (2013-09-01)

Is Chronic Varicocele a Risk Factor for Secondary Hyperparathyroidism?
by: Rossella Cannarella, et al.
Published: (2022-01-01)

THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Sungjin Chung, et al.
Published: (2012-06-01)

POS-640 FUNGAL PERITONITIS IN AUTOMATED PERITONEAL DIALYSIS : AN 18-YEAR SINGLE CENTRE EVALUATION
by: N. CHERNI, et al.
Published: (2021-04-01)

POS-582 HEMODIALYSIS AND CARDIOVASCULAR DISEASE OCCURRENCE
by: B. FANDRI, et al.
Published: (2021-04-01)

Advances in the treatment of secondary and tertiary hyperparathyroidism
by: Li-Xi Zhang, et al.
Published: (2022-12-01)

Complications after radiofrequency ablation of hyperparathyroidism secondary to chronic kidney disease
by: Li-Ping Lin, et al.
Published: (2023-12-01)

Cinacalcet for Severe Secondary Hyperparathyroidism in Children with End-stage Kidney Disease
by: Areej Adel Sheerah, et al.
Published: (2021-01-01)

Laboratory criteria for the persistence of secondary hyperparathyroidism in patients with chronic kidney disease
by: M. Urina, et al.
Published: (2020-11-01)

Association of Secondary Hyperparathyroidism with Hemoglobin Level in Patients with Chronic Kidney Disease
by: Happy Chutia, et al.
Published: (2013-01-01)

Association of Vitamin D and secondary hyperparathyroidism with anemia in diabetic kidney disease
by: Satyendra Kumar Sonkar, et al.
Published: (2018-01-01)

POS-531 LIPID PROFILE AND CARDIOVASCULAR RISK IN CHRONIC HEMODIALYSIS PATIENTS
by: I. Nasri, et al.
Published: (2021-04-01)

POS-639 PERITONEAL DIALYSIS-RELATED EOSINOPHILIC PERITONITIS : AN UNEXPECTED CAUSE OF REFRACTORY PERITONITIS A CASE REPORT
by: N. CHERNI, et al.
Published: (2021-04-01)

Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease
by: Friedl C, et al.
Published: (2017-05-01)

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
by: Fizza Abbas, et al.
Published: (2019-06-01)

Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis.
by: Ariadna Pérez-Ricart, et al.
Published: (2016-01-01)

Generalised osteitis fibrosa cystica due to secondary hyperparathyroidism in chronic kidney disease
by: Sundar K Shrestha, et al.
Published: (2014-01-01)

Risk factors of hyperkalemia after total parathyroidectomy in patients with secondary hyperparathyroidism
by: Yun Zou, et al.
Published: (2020-01-01)

A CASE OF NUTRITIONAL SECONDARY HYPERPARATHYROIDISM IN A DOG
by: J. Ashwin, et al.
Published: (2010-01-01)

Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism.
by: Renaud Felten, et al.
Published: (2019-01-01)

Kidney transplantation and hyperparathyroidism
by: O. N. Vetchinnikova
Published: (2017-06-01)

Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease
by: Stephen A. Strugnell, et al.
Published: (2023-02-01)

Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease
by: Valentina Lorenzoni, et al.
Published: (2014-09-01)

POS-076 DYSREGULATED PHOSPHOCALCIC METABOLISM IN ACUTE KIDNEY INJURY
by: H. ABID, et al.
Published: (2021-04-01)

Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment
by: Yu-Chi Kuo, et al.
Published: (2023-02-01)

Incidence of and risk factors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism
by: Latus J, et al.
Published: (2013-07-01)

Tumoral calcinosis, calciphylaxis, hyperparathyroidism and tuberculosis in a dialysis patient
by: Khawla Kammoun, et al.
Published: (2011-01-01)

POS-265 HYPERTENSION IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: Y. IZIDBIH, et al.
Published: (2021-04-01)